Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Nascent proteomes in peripheral blood mononuclear cells as a novel source for biomarker discovery in human stroke
Fang Bian1, Roger P Simon, Yun Li
1From the Department of Neurobiology (F.B., R.P.S., Y.L., A.Z.), and Clinical Research Center (J.W.), Morehouse School of Medicine, Atlanta, GA; Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Atlanta, GA (R.P.S., M.F.); Department of Biochemistry, Oregon Health Science University, Portland (L.D.); and Department of Neurology, Emory University, Atlanta, GA (C.L.H., M.F.).
Background And Purpose:
The proteome of newly synthesized proteins (nascent proteome) in peripheral blood mononuclear cells (PBMCs) can be a novel source of stroke biomarkers. Changes in the PBMC nascent proteome after stroke reflect the dynamic response-in-action not detectable in the total proteome (all existing proteins) in blood. Here, we test the application of nascent proteomics as a novel approach for stroke biomarker discovery.
Methods:
The PBMC nascent proteome in human blood was determined by metabolic labeling of fresh PBMC cultures with azidohomoalanine (an azide-containing methionine surrogate), followed by mass spectrometry detection and quantification of azidohomoalanine-labeled proteins. The PBMC nascent and total proteomes were compared between patients with stroke and matched controls.
Results:
Both PBMC nascent and total proteomes showed differences between stroke patients and controls. Results of hierarchical clustering analysis of proteomic data revealed greater changes in the nascent than in the total PBMC proteomes, supporting the usefulness of the PBMC nascent proteome as a novel source of stroke biomarkers.
Conclusions:
Nascent proteomes in PBMC can be a novel source for biomarker discovery in human stroke.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
08:22Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology